Modern Treatment Methods for Hip Osteoarthritis
DOI:
https://doi.org/10.31149/ijimm.v4i8.2966Keywords:
hip osteoarthritis, coxarthrosis, conservative treatment, pharmacological therapy, physical therapy, intra-articular injections, platelet-rich plasma, stem cell therapy, total hip arthroplasty, robotic-assisted surgery, computer navigation, artificial intelligence, regenerative medicine, personalized rehabilitationAbstract
Hip osteoarthritis is a progressive degenerative joint disease that causes chronic pain, impaired mobility, functional limitations, and reduced quality of life. The increasing prevalence of the disease, particularly among aging populations and individuals with obesity, previous trauma, developmental hip disorders, and other risk factors, emphasizes the need for effective and individualized treatment strategies. This review analyzes modern approaches to the management of hip osteoarthritis, including non-pharmacological interventions, pharmacological therapy, intra-articular injections, surgical procedures, and emerging technologies. Particular attention is given to patient education, weight management, exercise therapy, physical rehabilitation, walking aids, non-steroidal anti-inflammatory drugs, corticosteroid injections, hyaluronic acid, platelet-rich plasma, and stem cell-based therapies. Surgical options such as hip arthroscopy, corrective osteotomy, and total hip arthroplasty are also considered, with total hip arthroplasty remaining the most effective treatment for end-stage disease. In addition, the review examines the growing role of robotic-assisted surgery, computer navigation, and artificial intelligence in improving surgical precision, implant positioning, treatment planning, outcome prediction, and personalized rehabilitation. The analysis indicates that a multidisciplinary and patient-centered approach provides the most appropriate framework for managing hip osteoarthritis, while emerging regenerative and digital technologies may contribute to further improvements in long-term clinical outcomes. Continued high-quality clinical research is required to establish the safety, effectiveness, and long-term benefits of innovative treatment methods.
References
[1] C. P. Hannon, R. E. Delanois, S. Nandi, Y. A. Fillingham, and Management of Osteoarthritis of the Hip Work Group, “American Academy of Orthopaedic Surgeons Clinical Practice Guideline Summary: Management of Osteoarthritis of the Hip,” J. Am. Acad. Orthop. Surg., vol. 32, no. 20, pp. e1027–e1034, 2024, doi: 10.5435/JAAOS-D-24-00420.
[2] American Academy of Orthopaedic Surgeons, Management of Osteoarthritis of the Hip: Evidence-Based Clinical Practice Guideline. Rosemont, IL, USA: AAOS, 2023.
[3] R. R. Bannuru, M. C. Osani, E. E. Vaysbrot, et al., “OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis,” Osteoarthritis Cartilage., vol. 27, no. 11, pp. 1578–1589, 2019, doi: 10.1016/j.joca.2019.06.011.
[4] EULAR, “EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update,” Ann. Rheum. Dis., 2024.
[5] P. Moley et al., “Non-operative Treatment Options for Osteoarthritis in the Hip,” Curr. Rev. Musculoskelet. Med., vol. 16, pp. 628–639, 2023.
[6] Z. Fan, L. Yan, H. Liu, et al., “The prevalence of hip osteoarthritis: A systematic review and meta-analysis,” Arthritis Res. Ther., vol. 25, p. 51, 2023.
[7] I. G. Arslan, J. Damen, M. de Wilde, et al., “Estimating incidence and prevalence of hip osteoarthritis using electronic health records: A population-based cohort study,” Osteoarthritis Cartilage., vol. 30, no. 6, pp. 843–851, 2022.
[8] I. D. Learmonth, C. Young, and C. Rorabeck, “The operation of the century: Total hip replacement,” Lancet, vol. 370, no. 9597, pp. 1508–1519, 2007.
[9] J. T. Evans, J. P. Evans, R. W. Walker, et al., “How long does a hip replacement last? A systematic review and meta-analysis of case series and national registry reports,” Lancet, vol. 393, no. 10172, pp. 647–654, 2019.
[10] J. N. Katz, K. R. Arant, and R. F. Loeser, “Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review,” JAMA, vol. 325, no. 6, pp. 568–578, 2021.
[11] S. L. Kolasinski, T. Neogi, M. C. Hochberg, et al., “2020 American College of Rheumatology Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee,” Arthritis Care Res. (Hoboken), vol. 72, no. 2, pp. 149–162, 2020.
[12] D. J. Hunter and S. Bierma-Zeinstra, “Osteoarthritis,” Lancet, vol. 393, no. 10182, pp. 1745–1759, 2019.
[13] M. Cross, E. Smith, D. Hoy, et al., “The global burden of hip and knee osteoarthritis,” Ann. Rheum. Dis., vol. 73, no. 7, pp. 1323–1330, 2014.
[14] A. E. Nelson, “Osteoarthritis year in review 2023: Clinical,” Osteoarthritis Cartilage., 2024.
[15] G. A. Hawker, “Osteoarthritis is a serious disease,” Clin. Exp. Rheumatol., vol. 37, Suppl. 120, pp. 3–6, 2019.
